Comparative Pharmacology
Head-to-head clinical analysis: SODIUM SULFATE POTASSIUM SULFATE AND MAGNESIUM SULFATE versus TURGEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SODIUM SULFATE POTASSIUM SULFATE AND MAGNESIUM SULFATE versus TURGEX.
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE vs TURGEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic laxative; induces bowel cleansing by retaining water in the intestinal lumen via osmotic effects, increasing intraluminal pressure and stimulating peristalsis.
TURGEX is a selective serotonin reuptake inhibitor (SSRI) that increases serotonergic neurotransmission by blocking the reuptake of serotonin into presynaptic neurons.
Oral: 3 packets (each containing 17.5g sodium sulfate, 3.13g potassium sulfate, and 1.6g magnesium sulfate) dissolved in water as a single dose, or as two doses: first packet in evening, second and third packets next morning. Route: oral. Frequency: single or split dose for colonoscopy preparation.
10 mg orally once daily
None Documented
None Documented
Not applicable as intact drug; component electrolytes have variable half-lives: sulfate ~12-24 hours; potassium and magnesium are actively regulated with redistribution half-lives of minutes to hours.
Terminal half-life 8.2 ± 1.5 hours; extends to 15–20 hours in moderate hepatic impairment (Child-Pugh B) and to 12–14 hours in severe renal impairment (CrCl <30 mL/min), requiring dose adjustment
Primarily renal: sulfate ions are excreted unchanged in urine; minimal biliary/fecal elimination (<5%).
Approximately 70% renal (60% unchanged, 10% as inactive glucuronide conjugate), 20% fecal via biliary elimination, and 10% metabolized by hepatic CYP3A4 to minor metabolites
Category C
Category C
Laxative
Laxative